Jennison Associates
HZNP

Jennison Associates’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-213,669
Closed -$23.3M 643
2023
Q1
$23.3M Sell
213,669
-310,009
-59% -$33.8M 0.02% 306
2022
Q4
$59.6M Sell
523,678
-1,217,432
-70% -$139M 0.06% 162
2022
Q3
$108M Buy
1,741,110
+420,629
+32% +$26M 0.11% 107
2022
Q2
$105M Sell
1,320,481
-72,313
-5% -$5.77M 0.11% 108
2022
Q1
$147M Buy
1,392,794
+42,399
+3% +$4.46M 0.11% 96
2021
Q4
$146M Buy
1,350,395
+392,451
+41% +$42.3M 0.09% 94
2021
Q3
$105M Buy
957,944
+12,339
+1% +$1.35M 0.07% 114
2021
Q2
$88.5M Buy
945,605
+24,579
+3% +$2.3M 0.06% 136
2021
Q1
$84.8M Buy
921,026
+72,279
+9% +$6.65M 0.06% 141
2020
Q4
$62.1M Buy
848,747
+22,794
+3% +$1.67M 0.04% 172
2020
Q3
$64.2M Sell
825,953
-301,441
-27% -$23.4M 0.05% 143
2020
Q2
$62.7M Sell
1,127,394
-867,747
-43% -$48.2M 0.06% 137
2020
Q1
$59.1M Buy
1,995,141
+37,787
+2% +$1.12M 0.07% 121
2019
Q4
$70.9M Sell
1,957,354
-589,683
-23% -$21.3M 0.07% 151
2019
Q3
$69.4M Buy
2,547,037
+176,419
+7% +$4.8M 0.07% 154
2019
Q2
$57M Buy
2,370,618
+167,929
+8% +$4.04M 0.06% 190
2019
Q1
$58.2M Sell
2,202,689
-17,878
-0.8% -$473K 0.06% 198
2018
Q4
$43.4M Buy
2,220,567
+807,401
+57% +$15.8M 0.05% 234
2018
Q3
$27.7M Buy
+1,413,166
New +$27.7M 0.03% 349